Low
₹16,467.35
High
₹16,588.20
Low
₹13,536.50
High
₹16,921.05
| Previous Close | ₹16,581.85 |
|---|---|
| Day's Range | ₹16,467.35 - ₹16,588.20 |
| Open | ₹16,569.45 |
| 52 Week Range | ₹13,536.50 - ₹16,921.05 |
| Volume | 4,40,77,223 |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Cipla Ltd. | 1450.00 | |
Healthcare |
| Dr. Reddy's Laboratories Ltd. | 1200.00 | |
Healthcare |
| Lupin Ltd. | 2235.00 | |
Healthcare |
| Torrent Pharmaceuticals Ltd. | 4833.00 | |
Healthcare |
| Abbott India Ltd. | 27060.00 | |
Healthcare |
| Apollo Hospitals Enterprise Ltd. | 8920.50 | |
Healthcare |
| Ipca Laboratories Ltd. | 1734.20 | |
Healthcare |
| Sun Pharmaceutical Industries Ltd. | 1930.00 | |
Healthcare |
| Aurobindo Pharma Ltd. | 1622.10 | |
Healthcare |
| Glenmark Pharmaceuticals Ltd. | 2318.40 | |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24366.0 | 26373.20 | 22182.55 |
| Nifty IT | 31357.75 | 40301.40 | 25699.10 |
| Nifty Next 50 | 74486.55 | 74878.45 | 59896.10 |
| NIFTY50 USD Index | 8846.65 | 10443.40 | 8132.40 |
| Nifty Bank | 57491.1 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 63782.15 | 64139.05 | 52032.85 |
| Nifty 500 | 23594.9 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 18260.65 | 18403.50 | 14804.55 |
| Nifty 100 | 25524.85 | 26975.15 | 22720.45 |
| Nifty FMCG | 48615.05 | 58485.05 | 45334.15 |
Max Healthcare Institute has informed that Nomination and Remuneration Committee (‘NRC’) of the Company in its meeting held today, August 13, 2026, has approved the grant of 3,61,827 stock options to eligible employees under Max Healthcare Institute - Employee Stock Option Scheme 2022. Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. The NRC meeting commenced at 7.50 am (IST) and concluded at 8.20 am (IST). This disclosure will also be hosted on Company's website: ww.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Glenmark Pharmaceuticals has informed that the Company has allotted 23,863 Equity Shares of Re 1 each on August 10, 2026, to the grantee who had exercised the options under the Company's Employee Stock Option Plan 2016 (ESOP 2016). With this allotment, the paid-up capital of the Company has increased from Rs 28,22,00,809 divided into 28,22,00,809 number of equity shares of face value Re 1 each to Rs. 28,22,24,672 divided into 28,22,24,672 number of equity shares of face value Re 1 each. The details as required under the SEBI (Share Based Employee Benefits and Sweat equity) Regulations, 2021 are enclosed as Annexure - I.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biocon has informed that it enclosed the presentation with respect to Q1 FY27 Earnings Call to be conducted on August 06, 2026. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of NIFTYHEALTH index is ₹16505.3 as of 2026-08-14.
The total volume of NIFTYHEALTH index is 44077223.00 as of 2026-08-14.
The percentage change in value of NIFTYHEALTH index is -0.46% as of 2026-08-14.
The absolute increase in NIFTYHEALTH index value since the previous trading day is ₹-76.55 as of 2026-08-14.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.